OverviewSuggest Edit

Tubulis is a company that develops antibody drug conjugate assets. Its solutions are integrated with disease biology and address medical needs.
TypePrivate
Founded2012
Websitetubulis.com

Latest Updates

Employees (est.) (Oct 2020)7
Cybersecurity ratingAMore

Key People/Management at Tubulis

Dominik Schumacher

Dominik Schumacher

Founder, CEO
Jonas Helma-Smets

Jonas Helma-Smets

Founder, CSO
Ingo Lehrke

Ingo Lehrke

CBO
Show more

Tubulis Financials and Metrics

Summary Metrics

Founding Date

2012

Tubulis total Funding

$13.7 m

Tubulis latest funding size

$12.24 m

Time since last funding

3 months ago

Tubulis investors

Tubulis's latest funding round in July 2020 was reported to be $12.2 m. In total, Tubulis has raised $13.7 m
Show all financial metrics

Tubulis Cybersecurity Score

Cybersecurity ratingPremium dataset

A

99/100

SecurityScorecard logo

Tubulis Online and Social Media Presence

Embed Graph

Tubulis Frequently Asked Questions

  • When was Tubulis founded?

    Tubulis was founded in 2012.

  • Who are Tubulis key executives?

    Tubulis's key executives are Dominik Schumacher, Jonas Helma-Smets and Ingo Lehrke.

  • How many employees does Tubulis have?

    Tubulis has 7 employees.

  • Who are Tubulis competitors?

    Competitors of Tubulis include LifebankUSA, Braeburn Pharmaceuticals and NorthSea Therapeutics.